NCT03774589 (BAMCT) is a NA clinical trial of Magnetic Compressive Anastomosis in Pancreatic Cancer, sponsored by First Affiliated Hospital Xi'an Jiaotong University.

Who is sponsoring NCT03774589?

NCT03774589 is sponsored by First Affiliated Hospital Xi'an Jiaotong University.

What drugs are being tested in NCT03774589?

Interventions in NCT03774589: Magnetic Compressive Anastomosis, Manual Anastomosis.

What condition does NCT03774589 study?

NCT03774589 studies Pancreatic Cancer, Cholangiocarcinoma, Bile Duct Injury, Choledochal Cyst, Biliary Calculi.

Is NCT03774589 still recruiting?

NCT03774589 is currently status unknown. Last updated 18 November 2019.

Last reviewed 2019-11-18 · How we verify

NCT03774589: BAMCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bilioenteric Anastomosis by Magnetic Compressive Technique

Status unknown NA Last updated 18 November 2019

What this trial tests

NA trial testing Magnetic Compressive Anastomosis in Pancreatic Cancer in 200 participants. Status unknown.

Timeline

1 February 2019

Primary endpoint
31 January 2021

31 January 2022

Quick facts

Lead sponsor	First Affiliated Hospital Xi'an Jiaotong University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	200
Start date	1 February 2019
Primary completion	31 January 2021
Estimated completion	31 January 2022
Sites	1 location across China

Drugs / interventions tested

Magnetic Compressive Anastomosis
Manual Anastomosis

Conditions studied

Pancreatic Cancer — all drugs for Pancreatic Cancer →
Cholangiocarcinoma — all drugs for Cholangiocarcinoma →
Bile Duct Injury — all drugs for Bile Duct Injury →
Choledochal Cyst — all drugs for Choledochal Cyst →

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Who can join

Adults 18 to 75, any sex, with Pancreatic Cancer or Cholangiocarcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether the magnetic compressive anastomosis has a better outcomes than traditional manual anastomosis on bilioenteric anastomosis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Laparoscopic-assisted full-sized liver transplantation with magnetically fast portal vein anastomosis: an initial cohort study.
Liu XM, Li Y, Feng Z, Zhang XG, et al · · 2024 · cited 1× · PMID 38814355 · DOI 10.1097/js9.0000000000001730

Verify or expand the search:

Other trials of Magnetic Compressive Anastomosis

Trials testing the same drug.

NCT03792048 — Magnetic Compressive Anastomosis for Biliojejunostomy and Pancreaticojejunostomy During Whipple's Procedure · NA · unknown

Other recruiting trials for Pancreatic Cancer

Currently open trials in the same condition.

NCT07126158 — Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma · Phase 2 · recruiting
NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
NCT07409272 — A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherap · Phase 3 · recruiting
NCT07236177 — B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosi · EARLY_PHASE1 · recruiting

Other First Affiliated Hospital Xi'an Jiaotong University trials

Trials by the same sponsor.

NCT07389460 — Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) · Phase 3 · not yet recruiting
NCT07170176 — Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine · NA · recruiting
NCT07168291 — Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma · EARLY_PHASE1 · not yet recruiting
NCT06775782 — Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis · NA · recruiting
NCT07266467 — Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Dis · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03774589 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital Xi'an Jiaotong University
Last refreshed: 18 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03774589.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing